Dianthus Therapeutics (DNTH) Current Assets (2017 - 2025)
Historic Current Assets for Dianthus Therapeutics (DNTH) over the last 8 years, with Q3 2025 value amounting to $413.8 million.
- Dianthus Therapeutics' Current Assets rose 4394.46% to $413.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $413.8 million, marking a year-over-year increase of 4394.46%. This contributed to the annual value of $280.9 million for FY2024, which is 5829.95% up from last year.
- According to the latest figures from Q3 2025, Dianthus Therapeutics' Current Assets is $413.8 million, which was up 4394.46% from $263.6 million recorded in Q2 2025.
- Dianthus Therapeutics' Current Assets' 5-year high stood at $413.8 million during Q3 2025, with a 5-year trough of $78.6 million in Q2 2023.
- In the last 4 years, Dianthus Therapeutics' Current Assets had a median value of $191.5 million in 2023 and averaged $220.7 million.
- In the last 5 years, Dianthus Therapeutics' Current Assets plummeted by 4792.72% in 2023 and then skyrocketed by 36502.58% in 2024.
- Dianthus Therapeutics' Current Assets (Quarter) stood at $82.0 million in 2022, then surged by 116.32% to $177.5 million in 2023, then soared by 58.3% to $280.9 million in 2024, then soared by 47.32% to $413.8 million in 2025.
- Its Current Assets was $413.8 million in Q3 2025, compared to $263.6 million in Q2 2025 and $271.0 million in Q1 2025.